Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Monitoring serum concentrations of tumor necrosis factor antagonists in patients receiving these drugs as treatment for inflammatory bowel disease (IBD), also called therapeutic drug monitoring, is performed either after patient loss of response (reactive drug monitoring) or in patients in clinical...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical gastroenterology and hepatology Vol. 15; no. 10; p. 1580
Main Authors:	Papamichael, Konstantinos, Chachu, Karen A, Vajravelu, Ravy K, Vaughn, Byron P, Ni, Josephine, Osterman, Mark T, Cheifetz, Adam S
Format:	Journal Article
Language:	English
Published:	United States 01.10.2017
Subjects:	Adolescent Adult Drug Monitoring - methods Female Gastrointestinal Agents - administration & dosage Gastrointestinal Agents - blood Humans Inflammatory Bowel Diseases - drug therapy Infliximab - administration & dosage Infliximab - blood Male Retrospective Studies Serum - chemistry Treatment Outcome Young Adult Monitoring Therapy CD Immunogenicity Ulcerative Colitis
ISSN:	1542-7714, 1542-7714
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!